Form 4 for TPST Tempest Therapeutics, Inc.
Accepted 2024-07-08 00:00:00 ET · period of report 2024-07-03 · accession 0001415889-24-019339 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-08 | 2024-07-03 | TPST | Brady Stephen R | Pres, CEO, Dir | P - Purchase | $2.11 | +35.0K | 46.4K | +308% | +$73.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-03 | P | A | 35,000 | $2.11 | 46,376 | D | — | — | (F1) Includes 11,376 shares acquired under the Issuer's stock purchase plan. |